Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug ...

Did Novartis ($NVS) and Roche ($RHHBY) campaign against study data supporting cheap Avastin eye injections as a substitute for their own purpose-made vision drug ...

India has withdrawn an alert on off-label use of Roche's ($RHBBY) approved oncology drug Avastin to treat age-related macular degeneration after an expert committee ...

Genentech, Inc. would like to inform you of important safety information regarding off-label intravitreal use of AVASTIN® (bevacizumab). As of December 8, 2008, Genentech, Inc. through its global ...

The U.K. medicines regulator has determined that reformulating the Avastin cancer medicine into a treatment for a serious eye condition is a permitted off-label use, dealing another setback to Bayer ...

Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical ...

(Reuters) - The U.S. Department of Veterans Affairs said it has stopped using Roche's Avastin to treat a sight-robbing eye disease as it looks into reports of increased risk of infection. Roche's ...

PARIS, Nov 6 (Reuters) - French medicine agency ANSM has written to Roche asking the Swiss drugmaker for information on off-label uses of its cancer drug Avastin, which ANSM wants to let doctors ...

PHILADELPHIA-- Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more ...